Search Results - "McCartney, Amber J."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Phosphatidylinositol 3,5-bisphosphate: Low abundance, high significance by McCartney, Amber J., Zhang, Yanling, Weisman, Lois S.

    Published in BioEssays (01-01-2014)
    “…Recent studies of the low abundant signaling lipid, phosphatidylinositol 3,5‐bisphosphate (PI(3,5)P2), reveal an intriguingly diverse list of downstream…”
    Get full text
    Journal Article
  2. 2

    Local Presynaptic Activity Gates Homeostatic Changes in Presynaptic Function Driven by Dendritic BDNF Synthesis by Jakawich, Sonya K., Nasser, Hassan B., Strong, Michael J., McCartney, Amber J., Perez, Amanda S., Rakesh, Neal, Carruthers, Cynthia J.L., Sutton, Michael A.

    Published in Neuron (Cambridge, Mass.) (22-12-2010)
    “…Homeostatic synaptic plasticity is important for maintaining stability of neuronal function, but heterogeneous expression mechanisms suggest that distinct…”
    Get full text
    Journal Article
  3. 3

    Activity-dependent PI(3,5)P₂ synthesis controls AMPA receptor trafficking during synaptic depression by McCartney, Amber J, Zolov, Sergey N, Kauffman, Emily J, Zhang, Yanling, Strunk, Bethany S, Weisman, Lois S, Sutton, Michael A

    “…Significance Defects in biosynthesis of the signaling lipid phosphatidylinositol 3,5-bisphosphate [PI(3,5)P ₂] are associated with profound neurodegeneration…”
    Get full text
    Journal Article
  4. 4

    Retrograde changes in presynaptic function driven by dendritic mTORC1 by Henry, Fredrick E, McCartney, Amber J, Neely, Ryan, Perez, Amanda S, Carruthers, Cynthia J L, Stuenkel, Edward L, Inoki, Ken, Sutton, Michael A

    Published in The Journal of neuroscience (28-11-2012)
    “…Mutations that alter signaling through the mammalian target of rapamycin complex 1 (mTORC1), a well established regulator of neuronal protein synthesis, have…”
    Get full text
    Journal Article
  5. 5

    Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons by Cao, Mian, Wu, Yumei, Ashrafi, Ghazaleh, McCartney, Amber J., Wheeler, Heather, Bushong, Eric A., Boassa, Daniela, Ellisman, Mark H., Ryan, Timothy A., De Camilli, Pietro

    Published in Neuron (Cambridge, Mass.) (22-02-2017)
    “…Synaptojanin 1 (SJ1) is a major presynaptic phosphatase that couples synaptic vesicle endocytosis to the dephosphorylation of PI(4,5)P2, a reaction needed for…”
    Get full text
    Journal Article
  6. 6

    Meta‐analysis of NIH Alzheimer’s Disease‐Related Dementias (ADRD) programs responsive to the National Plan to Address Alzheimer’s Disease (AD) by McCartney, Amber J, Shukla, Arvind, Yin, Xiling, Dodson, Sara, Bryant, Erin, Corriveau, Roderick A

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background AD/ADRD diseases currently impact more than 6 million people in the US. Rare forms of AD/ADRD are caused directly and unambiguously by genetic…”
    Get full text
    Journal Article
  7. 7

    NINDS funding opportunities for Alzheimer’s Disease‐Related Dementia therapy development by Roof, Rebecca, Mcgavern, Linda, Boshoff, Chris, Lavaute, Timothy, Cywin, Charles, Thomas, Shruthi, McCartney, Amber J, Corriveau, Roderick A

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Goal 1 of the National Plan to Address Alzheimer’s Disease (AD) is to prevent and effectively treat AD and AD‐related dementias (ADRD) by 2025…”
    Get full text
    Journal Article
  8. 8

    Developing Topics by Roof, Rebecca, Mcgavern, Linda, Boshoff, Chris, Lavaute, Timothy, Cywin, Charles, Thomas, Shruthi, McCartney, Amber J, Corriveau, Roderick A

    Published in Alzheimer's & dementia (01-12-2023)
    “…Goal 1 of the National Plan to Address Alzheimer's Disease (AD) is to prevent and effectively treat AD and AD-related dementias (ADRD) by 2025. Toward this…”
    Get full text
    Journal Article
  9. 9

    Activity-dependent PI(3,5)P 2 synthesis controls AMPA receptor trafficking during synaptic depression by McCartney, Amber J., Zolov, Sergey N., Kauffman, Emily J., Zhang, Yanling, Strunk, Bethany S., Weisman, Lois S., Sutton, Michael A.

    “…Significance Defects in biosynthesis of the signaling lipid phosphatidylinositol 3,5-bisphosphate [PI(3,5)P 2 ] are associated with profound neurodegeneration…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Activity-dependent PI(3,5)P^sub 2^ synthesis controls AMPA receptor trafficking during synaptic depression by McCartney, Amber J, Zolov, Sergey N, Kauffman, Emily J, Zhang, Yanling, Strunk, Bethany S, Weisman, Lois S, Sutton, Michael A

    “…Dynamic regulation of phosphoinositide lipids (PIPs) is crucial for diverse cellular functions, and, in neurons, PIPs regulate membrane trafficking events that…”
    Get full text
    Journal Article
  12. 12

    Activity-dependent PI(3,5)P sub( 2) synthesis controls AMPA receptor trafficking during synaptic depression by McCartney, Amber J, Zolov, Sergey N, Kauffman, Emily J, Zhang, Yanling, Strunk, Bethany S, Weisman, Lois S, Sutton, Michael A

    “…Dynamic regulation of phosphoinositide lipids (PIPs) is crucial for diverse cellular functions, and, in neurons, PIPs regulate membrane trafficking events that…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Modulation of synaptic function by VAC14, a protein that regulates the phosphoinositides PI(3,5)P sub(2) and PI(5)P by Zhang, Yanling, McCartney, Amber J, Zolov, Sergey N, Ferguson, Cole J, Meisler, Miriam H, Sutton, Michael A, Weisman, Lois S

    Published in The EMBO journal (15-08-2012)
    “…Normal steady-state levels of the signalling lipids PI(3,5)P sub(2) and PI(5)P require the lipid kinase FAB1/PIKfyve and its regulators, VAC14 and FIG4…”
    Get full text
    Journal Article
  15. 15

    Modulation of synaptic function by VAC14, a protein that regulates the phosphoinositides PI(3,5)P2 and PI(5)P by Zhang, Yanling, McCartney, Amber J, Zolov, Sergey N, Ferguson, Cole J, Meisler, Miriam H, Sutton, Michael A, Weisman, Lois S

    Published in The EMBO journal (15-08-2012)
    “…Normal steady‐state levels of the signalling lipids PI(3,5)P 2 and PI(5)P require the lipid kinase FAB1/PIKfyve and its regulators, VAC14 and FIG4. Mutations…”
    Get full text
    Journal Article